annual CFI:
$37.67M+$67.23M(+227.46%)Summary
- As of today (May 29, 2025), KNSA annual cash flow from investing activities is $37.67 million, with the most recent change of +$67.23 million (+227.46%) on December 31, 2024.
- During the last 3 years, KNSA annual CFI has fallen by -$90.96 million (-70.71%).
- KNSA annual CFI is now -70.71% below its all-time high of $128.63 million, reached on December 31, 2021.
Performance
KNSA Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$51.54M-$116.83M(-178.94%)Summary
- As of today (May 29, 2025), KNSA quarterly cash flow from investing activities is -$51.54 million, with the most recent change of -$116.83 million (-178.94%) on March 31, 2025.
- Over the past year, KNSA quarterly CFI has dropped by -$77.06 million (-301.93%).
- KNSA quarterly CFI is now -158.05% below its all-time high of $88.79 million, reached on March 31, 2020.
Performance
KNSA quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$39.39M-$77.06M(-204.57%)Summary
- As of today (May 29, 2025), KNSA TTM cash flow from investing activities is -$39.39 million, with the most recent change of -$77.06 million (-204.57%) on March 31, 2025.
- Over the past year, KNSA TTM CFI has dropped by -$73.28 million (-216.25%).
- KNSA TTM CFI is now -115.93% below its all-time high of $247.32 million, reached on September 30, 2021.
Performance
KNSA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
KNSA Cash from investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +227.5% | -301.9% | -216.3% |
3 y3 years | -70.7% | -126.8% | -164.5% |
5 y5 years | -23.4% | -158.1% | -126.8% |
KNSA Cash from investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -70.7% | +227.5% | -178.9% | at low | -164.5% | +31.3% |
5 y | 5-year | -70.7% | +227.5% | -158.1% | +65.6% | -115.9% | +56.3% |
alltime | all time | -70.7% | +115.8% | -158.1% | +73.5% | -115.9% | +85.3% |
KNSA Cash from investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$51.54M(-178.9%) | -$39.39M(-204.6%) |
Dec 2024 | $37.67M(-227.5%) | $65.29M(-1128.6%) | $37.67M(-188.6%) |
Sep 2024 | - | -$6.35M(-86.4%) | -$42.52M(-12.2%) |
Jun 2024 | - | -$46.80M(-283.3%) | -$48.44M(-243.0%) |
Mar 2024 | - | $25.52M(-271.4%) | $33.89M(-214.6%) |
Dec 2023 | -$29.56M(+265.9%) | -$14.89M(+21.3%) | -$29.56M(-48.4%) |
Sep 2023 | - | -$12.28M(-134.6%) | -$57.32M(+120.4%) |
Jun 2023 | - | $35.53M(-193.7%) | -$26.01M(+11.7%) |
Mar 2023 | - | -$37.92M(-11.1%) | -$23.27M(+188.1%) |
Dec 2022 | -$8.08M(-106.3%) | -$42.66M(-324.1%) | -$8.08M(-47.7%) |
Sep 2022 | - | $19.04M(-50.2%) | -$15.46M(-215.8%) |
Jun 2022 | - | $38.27M(-268.4%) | $13.35M(-78.1%) |
Mar 2022 | - | -$22.72M(-54.6%) | $61.08M(-52.5%) |
Dec 2021 | $128.63M(-648.7%) | -$50.04M(-204.6%) | $128.63M(-48.0%) |
Sep 2021 | - | $47.85M(-44.4%) | $247.32M(+396.5%) |
Jun 2021 | - | $85.99M(+91.8%) | $49.81M(-173.9%) |
Mar 2021 | - | $44.83M(-34.7%) | -$67.40M(+187.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2020 | -$23.44M(-147.6%) | $68.64M(-145.9%) | -$23.44M(-74.0%) |
Sep 2020 | - | -$149.66M(+379.4%) | -$90.17M(-220.7%) |
Jun 2020 | - | -$31.22M(-135.2%) | $74.70M(-49.3%) |
Mar 2020 | - | $88.79M(+4534.1%) | $147.28M(+199.3%) |
Dec 2019 | $49.21M(-120.6%) | $1.92M(-87.4%) | $49.21M(-36.1%) |
Sep 2019 | - | $15.21M(-63.2%) | $76.96M(-157.8%) |
Jun 2019 | - | $41.36M(-545.8%) | -$133.13M(-46.4%) |
Mar 2019 | - | -$9.28M(-131.3%) | -$248.40M(+3.8%) |
Dec 2018 | -$239.20M(>+9900.0%) | $29.66M(-115.2%) | -$239.20M(-11.0%) |
Sep 2018 | - | -$194.87M(+163.7%) | -$268.86M(+263.2%) |
Jun 2018 | - | -$73.91M(>+9900.0%) | -$74.02M(>+9900.0%) |
Mar 2018 | - | -$75.00K(+1775.0%) | -$126.00K(+82.6%) |
Dec 2017 | -$69.00K(+2200.0%) | -$4000.00(-85.7%) | -$69.00K(+6.2%) |
Sep 2017 | - | -$28.00K(+47.4%) | -$65.00K(+75.7%) |
Jun 2017 | - | -$19.00K(+5.6%) | -$37.00K(+105.6%) |
Mar 2017 | - | -$18.00K | -$18.00K |
Dec 2016 | -$3000.00 | - | - |
FAQ
- What is Kiniksa Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual CFI year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly CFI year-on-year change?
- What is Kiniksa Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals TTM CFI year-on-year change?
What is Kiniksa Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of KNSA is $37.67M
What is the all time high annual CFI for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual cash flow from investing activities is $128.63M
What is Kiniksa Pharmaceuticals annual CFI year-on-year change?
Over the past year, KNSA annual cash flow from investing activities has changed by +$67.23M (+227.46%)
What is Kiniksa Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of KNSA is -$51.54M
What is the all time high quarterly CFI for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly cash flow from investing activities is $88.79M
What is Kiniksa Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, KNSA quarterly cash flow from investing activities has changed by -$77.06M (-301.93%)
What is Kiniksa Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of KNSA is -$39.39M
What is the all time high TTM CFI for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high TTM cash flow from investing activities is $247.32M
What is Kiniksa Pharmaceuticals TTM CFI year-on-year change?
Over the past year, KNSA TTM cash flow from investing activities has changed by -$73.28M (-216.25%)